Chiplytics Secures $4.5M for Microchip Verification

Chiplytics' $4.5M announcement combines 2 kinds of capital around one commercial handoff: $2.5M in Seed financing and a $2M U.S. Air Force Tactical Funding Increase award. The Seattle company is using that package to expand microelectronics inspection technology and operate a new laboratory inside Quality King's distribution center in Bellport, New York.

Scout Ventures and Waypoint Ventures led the Seed round. QK Special Services, Industrious Ventures, Interwoven Ventures, Alliance of Angels and Cornell University's Red Bear Angels also participated. The mix matters because private investors are backing the commercial operation while the Air Force is helping advance the underlying inspection platform. Together, the money supports lab buildout and hiring in testing and engineering.

What Chiplytics Announced

Chiplytics announced the financing and Bellport lab on October 6, 2026. GeekWire reported that the $4.5M total includes $2.5M of Seed capital and a $2M Air Force TACFI award, a distinction that keeps the capital accounting honest. The official announcement describes one funding package that includes the government award.

The lab operates inside Quality King's 600,000-square-foot distribution center and supports its QK Special Services division. That location is part of the product strategy. Chiplytics is trying to place sourcing, inspection, reporting and delivery close enough together that manufacturers do not have to assemble trust from separate vendors and separate records while a production deadline is moving.

The company says the proceeds will build out the Bellport operation and add testing and engineering talent. Its research and development headquarters remains in Seattle, creating a 2-site model: product and inspection technology development on the West Coast, then component testing and distribution on Long Island.

Why Component Verification Becomes Urgent

Semiconductor shortages create a buying problem before they create a technology problem. When an authorized distributor cannot deliver a critical part in time, manufacturers may turn to independent channels with more inventory and less direct manufacturer authorization. The alternative can keep a production line alive, but it also increases the work required to establish identity, condition and traceability.

Chiplytics is built around that pressure. President and co-founder Stephen DiBartolomeo told GeekWire that lead times for basic components can exceed 52 weeks. He also described a recent order for 50,000 parts, where manual inspection or traditional sampling would struggle to deliver the coverage and speed the customer needed.

Sampling is an economic compromise: inspect a fraction of the lot and infer something about the rest. That can be useful, but a uniform label does not guarantee a uniform history. Components can be counterfeit, substituted, remarked, mishandled or simply inconsistent with the performance expected by a high-reliability buyer.

How the Chiplytics Platform Works

The technical foundation is Power Spectrum Analysis developed at Sandia National Laboratories. PSA is a nondestructive electrical method that captures a component's pseudosignature, allowing different parts or lots to be compared for meaningful variation. Chiplytics licensed the technology and has spent several years converting it into products that can work beyond a national-lab setting.

Its inspection platform combines PSA with machine vision, automated handling and supplemental tests. The company says every unit can be imaged so package markings, part numbers and date or lot codes can be checked, while electrical signatures and other results are preserved for traceability. The Bellport lab can also use AS6171-aligned methods including X-ray, solderability verification, decapsulation and die inspection.

The phrase "AS6171-aligned" deserves precision. Chiplytics says its methods follow that inspection framework; the public announcement does not establish that the new lab itself holds an AS6171 accreditation. The useful claim is operational: buyers can approve a risk-based test plan, see part and verification costs separately, and receive a documented result tied to the components moving through the distribution chain.

The Team Behind the Commercialization

Co-founder and CEO Steven Dourmashkin leads product, software and operations after previously building and selling consumer-electronics startup Specdrums. Co-founder and President Stephen DiBartolomeo brings experience as a Navy cryptologic warfare officer and national-security investor to sales, procurement and capital.

CTO Connor Dempsey, PhD leads engineering, quality and R&D with a background in semiconductor physics. VP of Operations Devon Richman, PhD, runs the Verified by Chiplytics laboratory and brings experience across counterfeit-part testing, reliability and failure analysis.

That combination reflects the company's commercialization problem. The science has to detect meaningful electrical differences, the equipment has to operate repeatably, and the resulting evidence has to fit the purchasing and quality systems of organizations that cannot treat component failure as a minor inconvenience.

What the $4.5M Package Changes

The Seed financing gives Chiplytics capital to make the commercial system more repeatable. The TACFI award extends government support for inspection technology that has already moved through earlier Air Force research contracts. An SBIR award record shows a prior $1.78M Phase II STTR program focused on quantifiable assurance for mission-critical microelectronics.

The Bellport lab turns that development history into a more direct buyer proposition. Instead of selling only a testing instrument or asking a customer to build a new inspection workflow, Chiplytics can help source the part, assess the risk, execute the approved test plan and return traceable results within one service chain.

That approach still has to prove itself across more customers, part families and production environments. Chiplytics has not disclosed revenue, valuation or audited market-share data, and its defense and high-reliability customers remain largely unnamed. The next evidence will come from whether the lab can preserve inspection depth as order volume, component variety and turnaround pressure rise together.

For manufacturers, the wager is practical. The cost of inspecting a component arrives before installation; the cost of trusting the wrong component may arrive after it is embedded inside a vehicle, aircraft, industrial system or defense platform. Chiplytics is using this capital to move the evidence earlier, closer to the point where procurement still has a choice.